NCT05015530View on ClinicalTrials.gov

Impact of Symbiofilm On Nasal Microbiota

CompletedOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

December 12, 2022

Primary Completion Date

May 19, 2023

Study Completion Date

May 19, 2023

Conditions
Rhinosinusitis ChronicMicrobiome
Interventions
DEVICE

Healsea® Chronic, hypertonic seawater-based nasal spray supplemented with natural Symbiofilm® extract

Healsea® Chronic nasal spray will be administered twice daily (1 puff, 1-2 sec) in each nostril during 30 days

Trial Locations (1)

31400

Larrey Hospital, Toulouse

Sponsors
All Listed Sponsors
lead

Lallemand Pharma AG

INDUSTRY

NCT05015530 - Impact of Symbiofilm On Nasal Microbiota | Biotech Hunter | Biotech Hunter